A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication
Open Access
- 18 December 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (52)
Abstract
Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide. As the other positive-strand RNA viruses, it is believed to replicate its genome in a membrane-associated replication complex. However, current understanding of the host factors required for productive HEV infection is limited and the site as well as the composition of the HEV replication complex are still poorly characterized. To identify host factors required for HEV RNA replication, we performed a genome-wide CRISPR/Cas9 screen in permissive human cell lines harboring subgenomic HEV replicons allowing for positive and negative selection. Among the validated candidates, Ras-related early endosomal protein Rab5A was selected for further characterization. siRNA-mediated silencing of Rab5A and its effectors APPL1 and EEA1, but not of the late and recycling endosome components Rab7A and Rab11A, respectively, significantly reduced HEV RNA replication. Furthermore, pharmacological inhibition of Rab5A and of dynamin-2, required for the formation of early endosomes, resulted in a dose-dependent decrease of HEV RNA replication. Colocalization studies revealed close proximity of Rab5A, the HEV ORF1 protein, corresponding to the viral replicase, as well as HEV positive- and negative-strand RNA. In conclusion, we successfully exploited CRISPR/Cas9 and selectable subgenomic replicons to identify host factors of a noncytolytic virus. This approach revealed a role for Rab5A and early endosomes in HEV RNA replication, likely by serving as a scaffold for the establishment of functional replication complexes. Our findings yield insights into the HEV life cycle and the virus–host interactions required for productive infection.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_179424)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_207477)
- Novartis Foundation (18C140)
This publication has 67 references indexed in Scilit:
- The Hepatitis E Virus Capsid C-Terminal Region Is Essential for the Viral Life Cycle: Implication for Viral Genome Encapsidation and Particle StabilizationJournal of Virology, 2013
- Adaptation of a Genotype 3 Hepatitis E Virus to Efficient Growth in Cell Culture Depends on an Inserted Human Gene Segment Acquired by RecombinationJournal of Virology, 2012
- Rubicon controls endosome maturation as a Rab7 effectorProceedings of the National Academy of Sciences, 2010
- A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycleProceedings of the National Academy of Sciences, 2010
- Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumorPediatric Blood & Cancer, 2009
- Participation of Rab5, an Early Endosome Protein, in Hepatitis C Virus RNA Replication MachineryJournal of Virology, 2007
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- Rab5-activating protein 6, a novel endosomal protein with a role in endocytosisBiochemical and Biophysical Research Communications, 2006
- A Novel Membrane-anchored Rab5 Interacting Protein Required for Homotypic Endosome FusionJournal of Biological Chemistry, 2000
- Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transferCancer Gene Therapy, 2000